Ralph Niven
Hoofd Techniek/Wetenschap/O&O bij AEROVATE THERAPEUTICS, INC.
Vermogen: 34 706 $ op 30-04-2024
Profiel
Ralph Niven is currently the Chief Scientific Officer at Aerovate Therapeutics, Inc. Prior to his current position, he held various roles including Principal at Amgen, Inc., Senior Vice President-Preclinical Development at Windtree Therapeutics, Inc. from 2001 to 2005, Chief Technology Officer at APT Pharmaceuticals, Inc. from 2007 to 2012, and Principal at Advanced Inhalation Research, Inc. He also worked as a Principal at Novartis Pharmaceuticals Corp.
from 2012 to 2017 and at Megabios Corp.
Dr. Niven holds an MBA from George Washington University, a doctorate from the University of Kentucky, and an undergraduate degree from the University of Strathclyde.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 05-02-2024 | 1 609 ( 0.01% ) | 34 706 $ | 30-04-2024 |
Actieve functies van Ralph Niven
| Bedrijven | Functie | Begin |
|---|---|---|
| AEROVATE THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Ralph Niven
| Bedrijven | Functie | Einde |
|---|---|---|
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01-01-2017 |
APT Pharmaceuticals, Inc.
 APT Pharmaceuticals, Inc. BiotechnologyHealth Technology APT Pharmaceuticals, Inc. operated as a drug development company. The company was founded on December 15, 1999 and was headquartered in Burlingame, CA. | Hoofd Techniek/Wetenschap/O&O | 01-01-2012 |
| WINDTREE THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2005 |
Advanced Inhalation Research, Inc.
 Advanced Inhalation Research, Inc. Pharmaceuticals: MajorHealth Technology Part of Alkermes Plc, Advanced Inhalation Research, Inc. is a company that develops dry-powder drug delivery systems for respiratory patients. The company is based in Cambridge, MA. The company was founded by Terrance G. McGuire, Justin S. Hanes. Advanced Inhalation Research was acquired by Alkermes, Inc., part of Alkermes Plc from September 16, 2011 on February 01, 1999 for $114.54 million. | Corporate Officer/Principal | - |
| Megabios Corp. | Corporate Officer/Principal | - |
Opleiding van Ralph Niven
| University of Kentucky | Doctorate Degree |
| George Washington University | Masters Business Admin |
| University of Strathclyde | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| WINDTREE THERAPEUTICS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| AEROVATE THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
APT Pharmaceuticals, Inc.
APT Pharmaceuticals, Inc. BiotechnologyHealth Technology APT Pharmaceuticals, Inc. operated as a drug development company. The company was founded on December 15, 1999 and was headquartered in Burlingame, CA. | Health Technology |
| Megabios Corp. | Health Technology |
Advanced Inhalation Research, Inc.
Advanced Inhalation Research, Inc. Pharmaceuticals: MajorHealth Technology Part of Alkermes Plc, Advanced Inhalation Research, Inc. is a company that develops dry-powder drug delivery systems for respiratory patients. The company is based in Cambridge, MA. The company was founded by Terrance G. McGuire, Justin S. Hanes. Advanced Inhalation Research was acquired by Alkermes, Inc., part of Alkermes Plc from September 16, 2011 on February 01, 1999 for $114.54 million. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
